199
Views
116
CrossRef citations to date
0
Altmetric
Review Article

Experimental Colitis in Animal Models

&
Pages 529-537 | Published online: 08 Jul 2009
 

Abstract

Despite extensive research on their immunologic, biochemical, microbiologic, and epidemiologic aspects, the etiology and pathogenesis of ulcerative colitis and Crohn's disease (inflammatory bowel disease (IBD)) are still not known. Consequently, the therapeutic approach remains empiric. Nor do we know the ideal animal model for study of IBD. Nevertheless, important insight into the nature of the human disease may be obtained from the study in animals. In this article we discuss pathogenetic mechanisms of experimental colitis in various animal models.

SUMMARY

Colitis may be induced in animals by oral administration of sulfated polysaccharides (carrageenan, amylopectin sulfate, dextran sulfate), chemical irritation by rectal instillation of sensitization to DNCB or after one single administration of TNBS, and Arthus reaction induced by intravenous injection of immune complexes after chemical irritation of the colon, and by chemoattractant peptides such as FMLP. It appears rabbit produce increased amounts of eicosanoids similar to that found in human colitis. Thus, animal studies provide useful information on the origin, regulation, and function of inflammatory mediators. However, with the possible exception of the cotton-top tamarin, no animal model of induced or spontaneous inflammation of the colon is analogous to human ulcerative colitis in etiology, course of disease activity, or histology (114).

The observation that two different immune-mediated models gave similar results suggests that the colitis is not a specific response to delayed-type hypersensitivity or immune-complex-mediated reactions but rather an unspecific, stereotype response (125). The original disturbance may not determine the nature of the lesions ultiniately produced but may instead serve as an initiator of a final common immunologic pathway.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.